United States on pharmaceutical ingredients and pharmaceutical drugs originating in China, including an assessment of how and whether China could leverage its production of certain pharmaceutical ingredients as a means to coerce the United States or the partners and allies of the United States. (10) An assessment of the percentage of personal protective equipment produced globally that originates in China. (11) An assessment of the national security risks associated with any reliance by the United States on personal protective equipment originating in China, including an assessment of how and whether China could leverage its production of personal protective equipment as a means to coerce the United States or the partners and allies of the United States. (c) Coordination In carrying out subsection (a), the Director shall coordinate with the Director of the Central Intelligence Agency, the Director of the National Security Agency, the Director of the Defense Intelligence Agency, the Director of the National Geospatial-Intelligence Agency, and any other relevant head of an element of the intelligence community. (d) Form The report submitted to the appropriate congressional committees under subsection (a) shall be submitted in unclassified form, but may include a classified annex. (e) Appropriate congressional committees defined In this section, the term appropriate congressional committees means— (1) the congressional intelligence committees